Kolexia
Martin Sophie Oncologie médicale
Martin Sophie
Oncologie médicale
Centre Paul Strauss
Strasbourg, France
49 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Défaillance cardiaque Inflammation Gliome Tumeurs du sein Métastase tumorale Carcinome épidermoïde Sarcomes Lupus érythémateux disséminé

Collaborateurs

Voir plus
Pierard Laure
Pierard Laure
Hôpital Hautepierre, Strasbourg, France
Barthelemy Philippe
Barthelemy Philippe
Hôpital Civil, Strasbourg, France
Schuster Caroline
Schuster Caroline
Centre Paul Strauss, Strasbourg, France
Trensz Philippe
Trensz Philippe
Hôpital Hautepierre, Strasbourg, France

Industries

Voir plus
Ipsen
6 collaboration(s)
Dernière en 2023
BMS
5 collaboration(s)
Dernière en 2023
Janssen
4 collaboration(s)
Dernière en 2023
Pharma Mar
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
CRYODESMO-02: A Phase II Multicentric, Randomized Trial Assessing Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting
Essai Clinique (CHU Strasbourg)   15 mars 2024
IRE1 RNase controls CD95-mediated cell death.
EMBO reports   21 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
ePPS-2202: Phase 3 Superiority Trial Evaluating the Benefit of Dematerialized Information Media for Patients With Advanced Sarcomas Receiving Second Line Treatment.
Essai Clinique (Centre Oscar-Lambret)   24 janvier 2024
IRE1 endoribonuclease signaling promotes myeloid cell infiltration in glioblastoma.
Neuro-oncology   28 décembre 2023
MegaMOST - A Multicenter, Open-label, Biology Driven, Phase II Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations /Characteristics in Advanced / Metastatic Tumors.
Essai Clinique (Centre Léon-Bérard)   16 novembre 2023
CN15 Real-life clinical and organizational evaluation of telemonitoring and assisted telemonitoring in more than 1500 cancer patients
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
2054P Metastatic cancer patients hospitalized at initial diagnosis: When does rescue systemic therapy make sense? ONIRIS - A national, prospective study
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Metalloprotease-mediated cleavage of CD95 ligand.
The FEBS journal   08 février 2023
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.
Clinical breast cancer   13 octobre 2022